Renamed center will include clinical care and research
More results...
Renamed center will include clinical care and research
MDMA is one step closer to becoming the first FDA-approved psychedelic drug. In October 2023, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced it completed its phase three clinical trial...